BioCentury | May 16, 2016
Company News

RXi Pharmaceuticals, Thera Neuropharma deal

...licensed exclusive rights to RXi’s sd-rxRNA platform to develop and commercialize therapeutics for neurodegenerative diseases. Thera Neuropharma...
...sclerosis (ALS). The companies declined to disclose financial terms. RXi Pharmaceuticals Corp. (NASDAQ:RXII), Westborough, Mass. Thera Neuropharma Inc....
Items per page:
1 - 1 of 1
BioCentury | May 16, 2016
Company News

RXi Pharmaceuticals, Thera Neuropharma deal

...licensed exclusive rights to RXi’s sd-rxRNA platform to develop and commercialize therapeutics for neurodegenerative diseases. Thera Neuropharma...
...sclerosis (ALS). The companies declined to disclose financial terms. RXi Pharmaceuticals Corp. (NASDAQ:RXII), Westborough, Mass. Thera Neuropharma Inc....
Items per page:
1 - 1 of 1